Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1687861000001117 | Budesonide 100micrograms/dose / Formoterol 3micrograms/dose inhaler CFC free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1687871000001110 | Budesonide 100micrograms/dose / Formoterol 3micrograms/dose inhaler CFC free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Symbicort 100micrograms/dose / 3micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) | Is a | True | Budesonide 100micrograms/dose / Formoterol 3micrograms/dose inhaler CFC free | Inferred relationship | Existential restriction modifier | |
Budesonide 100micrograms/dose / Formoterol 3micrograms/dose inhaler CFC free 120 dose | Has VMP | True | Budesonide 100micrograms/dose / Formoterol 3micrograms/dose inhaler CFC free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets